Research technology firm uMed has secured £3.7 million in venture capital funding, which will enable it to help healthcare providers in both the UK and US improve the efficiency of their patient research, while ensuring regulatory compliance and the safeguarding of patient data.

The funders backing the latest uMed round include venture capital investors AlbionVC, Delin Ventures and Playfair Capital, as well as US Silicon Valley firm 11.2 Capital.

uMed’s is delivering its technology to several clinical research studies, including the RAPTOR-C19 study, led by the University of Oxford, which is part of the COVID-19 National Diagnostic Research and Evaluation Platform (CONDOR).

RAPTOR-C19 compares the accuracy of various rapid COVID-19 tests for patients in community settings. uMed technology enables the study to digitally target and engage patients, through features such as e-consent and the automated capture of structured outcomes. uMed’s technology helps to ensure the study’s efficiency across numerous sites.

The uMed platform is already in use across a global network of 1.7 million patients at over 160 UK primary care sites, as well as 2 million patients from a US health system which will be available from early 2021.

uMed Founder and CEO Dr Matt Wilson says: “Our technology can support healthcare providers in finding appropriate patients to participate in medical research including large scale patient registries which usually demands laborious, manual processes on top of their already complex and heavy workloads.”

“As our technology is uniquely able to reach back compliantly from the Electronic Health Record (EHR) to the patients, the process for building research registries can be heavily automated. It means clinicians can focus on patient care, while patients are given the opportunity to participate in many more studies from home with full transparency over use of their health records.”

Contact us


Tel: +44 (0)1424 777745

Fax: +44 (0)1424 777746



Kirkham Young Ltd.
The Old Court House
North Trade Road
East Sussex
TN33 0EX